“You’re always thinking, ‘Hey, is this the day?’”

To keep babies healthy, a New Orleans case manager delivers stability in the face of federal uncertainty.

November 24, 2025 Check out STAT+

Sponsored By

Camille Farrah Lenain for STAT To keep babies healthy, a New Orleans case manager delivers stability in the face of federal uncertainty A look at Healthy Start, an infant-mortality prevention program long targeted for budget cuts, from the perspective of a Louisiana caseworker By Eric Boodman STAT+ | Trump weighs plan to extend extra ACA subsidies for two years With political backlash growing to surging health insurance costs, Trump administration floats temporary extension of Obamacare subsidies. By John Wilkerson 'Hemp loophole' closure pits patient access against a runaway marijuana industry Law to ban intoxicating cannabis products will also ban non-intoxicating CBD products used by many for nausea, pain, anxiety, insomnia and more. By Lev Facher Molly Ferguson for STAT STAT+ | Opinion: Tech-enabled caregiving can help dementia patients stay at home — perhaps for too long We need a new profession dedicated to using technology to monitor and support people living with Alzheimer's and other forms of dementia. By Jason Karlawish STAT+ | Novo Nordisk's semaglutide fails to slow Alzheimer's progression The drug, the key ingredient in Ozempic and Wegovy, did not outperform placebo in two trials, studies that had been considered long shots. By Andrew Joseph and Elaine Chen STAT+ | J&J's novel Alzheimer's drug fails in key trial, dimming hopes for a hot target The results could cast shadow over other experimental therapies aimed at the protein tau from companies including Biogen, UCB, and Voyager. By Damian Garde and Jason Mast Adobe STAT+ | Is Slingshot's mental health chatbot safe? Its first study raises questions about evaluating AI Slingshot AI publishes new data showing its chatbot Ash is safe and helpful, but experts say the small, uncontrolled study offers little clinical proof. By Mario Aguilar STAT+ | Medicare backs off plan for quicker clawback of $7.8 billion from hospitals The Trump administration caved to the demands of hospitals, for now, but will move forward with drug cost surveys. By Bob Herman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser